SCHEMBL626577

SCHEMBL626577

O=C(O)c1cnc2cccnc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.61
ALDH1A1 P00352 5/20 0.46
ALOX15 P16050 2/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
APP P05067 1/20 0.46
GAA P10253 1/20 0.46
HCAR3 P49019 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
MAPT P10636 3/20 0.45
PSMD14 O00487 1/20 0.45
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA5 P31644 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA2 P47869 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7010609 0.98 MGAM (0.59) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL27309407 0.87 MGAM (0.44) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL1198665 0.84 F7 (0.47) MGAMALDH1A1MAPTPSMD14NPC1
SCHEMBL123372 0.84 MAP4K4 (0.44) MGAMALDH1A1ALOX15MAPTNPC1
SCHEMBL30628188 0.84 F7 (0.47) MGAMALDH1A1MAPTPSMD14NPC1
SCHEMBL27822223 0.83 MGAM (0.44) MGAMALDH1A1ALOX15HPGDHSD17B10
Quinoline SCHEMBL28116161 0.83 MGAM (0.84) MGAMALDH1A1ALOX15GAAMAPT
Hydrochloric Acid SCHEMBL14966719 0.82 F7 (0.46) MGAMALDH1A1MAPTPSMD14NPC1
Benzoic Acid SCHEMBL28624673 0.80 NAPRT (0.61) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL31042186 0.80 ALOX15 (0.59) ALDH1A1ALOX15GAAMAPTPSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113825756-A Substituted polycyclic carboxylic acids, analogs thereof, and methods of use thereof 爱彼特生物制药公司 2021-12-21 CN claimed
CN-107820496-B Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prevention of hepatitis B virus infections 豪夫迈·罗氏有限公司 2020-11-03 CN claimed
CN-110475777-A For treating and preventing new pyrido [2,3-b] benzazolyl compounds of bacterium infection HOFFMANN LA ROCHE 2019-11-19 CN claimed
CN-106632317-A 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and application thereof 江苏欧威医药有限公司 2017-05-10 CN claimed
CN-104203945-B 1, 4-dihydro-naphthyridine derivatives, pharmaceutical compositions and uses thereof 江苏欧威医药有限公司 2017-01-18 CN claimed
CN-105481851-A Hexahydrobenzonaphthyridine-type optically active compound and pharmaceutical use thereof ZHAOLONG GONG 2016-04-13 CN claimed
CN-104203945-A 1, 4-dihydro-naphthyridine derivatives, pharmaceutical compositions and uses thereof JIANGSU SIMOVAY PHARMACEUTICAL CO LTD 2014-12-10 CN claimed
CN-103889414-A pharmaceutical composition RAQUALIA PHARMA INC 2014-06-25 CN claimed
CN-102574840-B R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same ARMED INC 2014-05-28 CN claimed
CN-102574840-A R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same ARIMED INC 2012-07-11 CN claimed
CN-1150181-C Substituted benzopyran analogs for treatment of inflammation GD 2004-05-19 CN claimed
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004014367-A2 USE OF AN AMYLOID BETA VACCINATION IN COMBINATION WITH A SELECTIVE COX-2 INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE PHARMACIA CORPORATION (US) 2004-02-19 WO claimed
WO-2004004833-A1 USE OF CYCLOOXYGENASE-2 SELECTIVE INHIBITORS AND THROMBOLYTIC AGENTS FOR THE TREATMENT OR PREVENTION OF A VASO-OCCLUSIVE EVENT PHARMACIA CORPORATION (US) 2004-01-15 WO claimed
WO-2003015608-A2 COMBINATION THERAPY FOR THE TREATMENT OF CANCER SUGEN, INC. (US) 2003-02-27 WO claimed
CN-1377347-A Pharmaceutically active sulfonamide derivatives APPLIED RESEARCH SYSTEMS (NL) 2002-10-30 CN claimed
EP-1230235-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES New Pharma Research Sweden AB (SE) 2002-08-14 EP claimed
WO-2001036408-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES NEW PHARMA RESEARCH SWEDEN AB (SE) 2001-05-25 WO claimed
CN-1257489-A Substituted benzopyran derivatives for the treatment of inflammation SEARLE & CO (US) 2000-06-21 CN claimed
WO-1995007909-A1 ALKYL-1-ALKYL-4-HYDROXY-2-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLATES AS ANTI-RHEUMATIC AGENTS KNOLL AG (DE) 1995-03-23 WO claimed